ates of ours may be adverse to your interests as an investor in the Notes. Please see the section of the accompanying Product Supplement entitled —Risk Factorsil for a more detailed discussion of these risks. 13 EFTA01470182 Certain risks specifically relating to the Reference Commodity Please refer to t